N-(3-氯苯基)-1H-吡唑并[4,3-b]-3-氨基吡啶 | 1041026-55-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-(3-氯苯基)-1H-吡唑并[4,3-b]-3-氨基吡啶
• 中文别名: (3-(溴甲基)-1-甲苯磺酰氮杂啶-3-基)甲醇
• 英文名称: (3-(bromomethyl)-1-tosylazetidin-3-yl)methanol
• 英文别名: (3-(bromomethyl)-1-(p-toluenesulfonyl)azetidin-3-yl)methanol；[3-(bromomethyl)-1-(4-methylphenyl)sulfonylazetidin-3-yl]methanol
• CAS: 1041026-55-4
• 化学式: C₁₂H₁₆BrNO₃S
• 分子量: 334.234
• InChiKey: KQQMWQUXNMGDNO-UHFFFAOYSA-N

物化性质

• 熔点：
  85-88 °C
• 沸点：
  462.7±51.0 °C(Predicted)
• 密度：
  1.541±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  66
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2933990090
• 包装等级：
  III
• 危险类别：
  6.1
• 危险性防范说明：
  P301+P310,P305+P351+P338
• 危险品运输编号：
  2811
• 危险性描述：
  H301,H319

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: (3-(Bromomethyl)-1-(p-toluenesulfonyl)azetidin-3-yl)methanol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: (3-(Bromomethyl)-1-(p-toluenesulfonyl)azetidin-3-yl)methanol
CAS number: 1041026-55-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C12H16BrNO3S
Molecular weight: 334.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-(3-氯苯基)-1H-吡唑并[4,3-b]-3-氨基吡啶 在 sodium sulfide trihydrate 、 三乙胺 、 三苯基膦 作用下， 以 甲醇 、 二氯甲烷 、 水 、 乙腈 为溶剂， 反应 21.67h， 生成 2-硫-6-氮杂螺[3.3]庚烷-6-甲酸叔丁酯
  参考文献：
  名称：

  多环磺胺类药物作为药物发现的新支架

  摘要：

  这项工作介绍了三种新型的含亚砜亚砜的多环支架的设计和合成，这表明亚砜亚胺代表了发现新候选药物的真正机会。另外，该结构具有至少两个多样化点并且包含高水平的sp 3-字符，因此是非常有趣的3D支架。将合成的化合物添加到欧洲铅工厂的化合物馆藏中。

  DOI：

  10.1021/acscombsci.7b00150
• 作为产物：
  描述：

  三溴新戊醇 在 氢溴酸 、 溶剂黄146 、 potassium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 61.0h， 生成 N-(3-氯苯基)-1H-吡唑并[4,3-b]-3-氨基吡啶
  参考文献：
  名称：

  硫杂环丁烷和其他环状硫化物的不同开环：亲电子芳烃活化方法

  摘要：

  有机硫化物是生物活性分子和功能材料中常见的一类结构单元，可促进有效合成方法的不断发展。在这里，我们报告一个或两个含有饱和硫杂环的杂原子的亲电芳烃活化的开环方案。这种三组分转化在温和的反应条件下进行，并显示出亲核试剂（C，O，S，N和F中心的亲核试剂）具有出色的通用性，从而以高收率得到结构多样的硫醚。

  DOI：

  10.1039/c7cc08553b

文献信息

• Diverse ring opening of thietanes and other cyclic sulfides: an electrophilic aryne activation approach
  作者：Tianyu Zheng、Jiajing Tan、Rong Fan、Shuaisong Su、Binbin Liu、Chen Tan、Kun Xu

  DOI：10.1039/c7cc08553b

  日期：——

  Organosulfides are a common class of structure units in bioactive molecules and functional materials motivating continuous developments of efficient synthetic methods. Herein, we report an electrophilic aryne-activated ring opening protocol of one or two heteroatom containing saturated sulfur heterocycles. This three-component transformation proceeds under mild reaction conditions and displays exceptional

  有机硫化物是生物活性分子和功能材料中常见的一类结构单元，可促进有效合成方法的不断发展。在这里，我们报告一个或两个含有饱和硫杂环的杂原子的亲电芳烃活化的开环方案。这种三组分转化在温和的反应条件下进行，并显示出亲核试剂（C，O，S，N和F中心的亲核试剂）具有出色的通用性，从而以高收率得到结构多样的硫醚。
• KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME
  申请人：Pauls Heinz W.

  公开号：US20140005167A1

  公开（公告）日：2014-01-02

  The present teachings provide a compound represented by structural formula (I): or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.

  本教学提供了一种由结构式(I)表示的化合物，或其药用可接受的盐。还描述了药物组合物及其使用方法。
• 4-AZAINDOLE COMPOUNDS
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20190185469A1

  公开（公告）日：2019-06-20

  Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R 1 , R 5 , and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.

  公开的是Formula (I)的化合物N-氧化物，或其盐，其中G，A，R1，R5和n在此处被定义。还公开了使用这些化合物作为Toll样受体7、8或9信号抑制剂的方法，以及包含这些化合物的药物组合物。这些化合物在治疗炎症性和自身免疫性疾病方面是有用的。
• Synthesis of Azaspirocycles and their Evaluation in Drug Discovery
  作者：Johannes A. Burkhard、Björn Wagner、Holger Fischer、Franz Schuler、Klaus Müller、Erick M. Carreira

  DOI：10.1002/anie.200907108

  日期：2010.5.3

  Make it spiro! Readily synthesized heteroatom‐substituted spiro[3.3]heptanes generally show higher aqueous solubility than their cyclohexane analogues, and show a trend towards higher metabolic stability. The novel framework can be mounted onto scaffolds of druglike structures, such as fluoroquinolones, to afford active compounds with similar or even improved metabolic stability.

  使它变成螺旋形！现成的杂原子取代的螺[3.3]庚烷通常比其环己烷类似物具有更高的水溶性，并显示出更高的代谢稳定性。可以将新的框架安装在药物样结构的支架上，例如氟喹诺酮，以提供具有相似或什至改善的代谢稳定性的活性化合物。
• [EN] SUBSTITUTED PHENYLOXAZOLIDINONES FOR ANTIMICROBIAL THERAPY<br/>[FR] PHENYL-OXAZOLIDINONES SUBSTITUÉES POUR LA THÉRAPIE ANTIMICROBIENNE
  申请人：THE GLOBAL ALLIANCE FOR TB DRUG DEV INC

  公开号：WO2017015106A1

  公开（公告）日：2017-01-26

  The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.

  本发明涉及新型噁唑烷酮（化学式I）：或具有由含氮的单环、双环或螺环取代基特征的环A的药用盐，以及其制备方法，以及作为用于治疗结核分枝杆菌和其他微生物感染的药物的用途，可以单独使用或与其他抗感染治疗结合使用。